Crawford Lake Capital Management, LLC Alnylam Pharmaceuticals, Inc. Transaction History

Crawford Lake Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$88.31 - $107.8 $9.28 Million - $11.3 Million	-105,099 Closed	0 $0
Q1 2018 May 14, 2018	SELL	$115.92 - $148.54 $1.28 Million - $1.64 Million	-11,029 Reduced 9.5%	105,099 $12.5 Million
Q4 2017 Feb 14, 2018	BUY	$114.49 - $139.98 $6.41 Million - $7.84 Million	56,002 Added 93.14%	116,128 $14.8 Million
Q3 2017 Nov 14, 2017	BUY	$72.53 - $118.27 $4.36 Million - $7.11 Million	60,126	60,126 $7.06 Million

638

107M

2.33M

2.15M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $32.6B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Crawford Lake Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Crawford Lake Capital Management, LLC with notifications on news.